Can liver stress or gut dysbiosis lower T3 availability?

The liver and the gut microbiome act as critical partners in maintaining thyroid hormone homeostasis, specifically regulating the peripheral activation and recycling of triiodothyronine (T3).

Hepatic activation and stress

• The liver is a primary site for peripheral thyroid hormone conversion, where hepatocytes express type 1 deiodinase (DIO1) to convert inactive thyroxine (T4) into active T3. This pathway contributes approximately 30% to 40% of systemic T3.
• Hepatic stress, chronic inflammation, and metabolic dysfunction-associated steatohepatitis (MASH) suppress DIO1 transcription and accelerate its degradation. This enzymatic downregulation—often accompanied by the upregulation of the inactivating enzyme DIO3—directly impairs T4-to-T3 conversion, leading to local and systemic reductions in T3 availability.

Microbial recycling and enterohepatic circulation

• Conjugated thyroid hormones (glucuronides and sulfates) excreted in bile must be deconjugated in the intestinal lumen to be successfully reabsorbed back into circulation.
• This crucial deconjugation step is driven by microbial β-glucuronidases and sulfatases. Gut dysbiosis alters the abundance of these enzyme-producing taxa, preventing hormone reabsorption and interrupting enterohepatic circulation.
• Furthermore, gut dysbiosis reduces the production of microbiota-derived short-chain fatty acids (SCFAs), such as butyrate and propionate. Because SCFAs serve to upregulate and modulate hepatic deiodinase expression, their depletion further suppresses the liver's capacity to activate thyroid hormones.

Bottom line

• Hepatic stress and gut dysbiosis independently and synergistically impair peripheral thyroid hormone metabolism—by suppressing hepatic DIO1-mediated conversion and disrupting microbial enterohepatic recycling—directly contributing to reduced peripheral T3 availability.